Have a personal or library account? Click to login
Change of TGF-β1 concentration in blood serum of patients during systemic treatment of severe psoriasis Cover

Change of TGF-β1 concentration in blood serum of patients during systemic treatment of severe psoriasis

Open Access
|Feb 2012

References

  1. Ahmad Fadzil, M.H., Ihtatho, D., Affandi, A.M., Hussein, S.H. (2008). Objective assessment of psoriasis erythema for PASI scoring. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society, pp. 4070-4073.
  2. Arsura, M., Wu, M., Sonenshein, G.E. (1996). TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha. Immunity, 5, 31-40.10.1016/S1074-7613(00)80307-6
  3. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A.A., Rojkind, M. Bottinger, E.P. (2000) A mechanism of suppression of TGF-β/SMAD signalling by NF-κB/Rela. Genes. Dev., 14, 187-197.
  4. Caserta, T.M., Knisley, A.A., Tan, F.K., Arnett, F.C., Brown, T.L. (2004). Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet., 47(4), 359-363.10.1016/j.anngen.2004.07.003
  5. Chen, L.Z., Hochwald, G.M., Huang, C., Dakin, G., Tao, H., Cheng, C. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1. Proc. Natl. Acad. Sci. USA, 95, 12516-12521.10.1073/pnas.95.21.12516
  6. Cueller, M.L., Espinoza L.R. (1997). Methotrexate use in psoriasis and psoriatic arthritis. Rheum. Dis. Clin. North Amer., 23, 797-809.10.1016/S0889-857X(05)70361-6
  7. Dahler, A.L., Cavanagh, L.L., Saunders, N.A. (2001). Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways. Invest. Dermatol., 116(2), 266-274.10.1046/j.1523-1747.2001.01243.x11180003
  8. De Jong, R., R.AW., van Lier, F.W., Ruscetti, C., Schmitt, P., Debre, M.D. Mossalayi (1993) Differential effect of transforming growth factor-β1 on the activation of human naive and memory CD4+ T lymphocytes. Int. Immunol., 6, 631-638.
  9. Dennler, S., Goumans, M.-J. Dijke, P. (2002) Transforming growth factor β signal transduction. J. Leuk. Biol., 71, 731-740.
  10. Elder, J.T., Ellingsworth, L.R., Fisher, G.J., Voorhees, J.J. (1990). Transforming growth factor-beta in psoriasis. Pathogen. Ther. Ann. NY Acad. Sci., 593, 218-230.10.1111/j.1749-6632.1990.tb16114.x2165376
  11. Fantini, M.C., Becker, C., Monteleone, G., Pallone, F., Galle, P.R., Neurath, M.F. (2004). Cutting edge, TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol., 172(9), 5149-5153.10.4049/jimmunol.172.9.514915100250
  12. Gamblicher, T., Breuckmann, F., Boms, S. (2005). Narrowband UVB phototherapy in skin conditions beyond psoriasis. J. Amer. Acad. Dermatol., 53, 1099-1000.
  13. Go, C., Li, P. Wang, X.-J. (1999). Blocking transforming growth factor β signaling in transgenic epidermis accelerates chemical carcinogenesis. A mechanism associated with increased angiogenesis. Cancer Res., 59, 2861-2868.
  14. Gray, J.D., Hirokawa, M., Horwitz, D.A. (1994). The role of transforming growth factor β in the generation of suppression, an interaction between CD8+ T and NK cells. J. Exp. Med., 180, 1937-1942.10.1084/jem.180.5.193721917187964469
  15. Hammad, A.M., Youssef, H.M., El-Arman, M.M. (2006). Transforming growth factor beta 1 in children with systemic lupus erythematosus, a possible relation with clinical presentation of lupus nephritis. Lupus, 15(9), 608-612.10.1177/096120330607187317080918
  16. Han, K.-H., Choi, H.-R., Won, C.-H., Chung, J-H., Cho, K.-H., Eun, H.-C., Kim, K.-H. (2005). Alteration of the TGF-β/SMAD pathway in intrinsically and UV-induced skin aging. Mech. Ageing Devel., 126, 560-567.10.1016/j.mad.2004.11.00615811425
  17. Hönigsmann, H. (2001). Phototherapy for psoriasis. Clin. Exp. Dermatol., 6, 343-350.10.1046/j.1365-2230.2001.00828.x
  18. Horwitz, D.A., Gray, D.K. Ohtsuka (1999). Role of NK cells and TGF-β in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect., 1(5), 1305-1311.10.1016/S1286-4579(99)00253-1
  19. Jeffes, E.W., McCullough, J.L., Pittelkow, M.R. (1995). Methotrexate therapy of psoriasis, differential sensitivity of proliferating lymphoid andepithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate. J. Invest. Dermatol., 104, 183-188.10.1111/1523-1747.ep12612745
  20. Khalil, N. (1999). TGF-beta: From latent to active. Microbes Infect., 1(15), 1255-1263.10.1016/S1286-4579(99)00259-2
  21. Laouar, Y., Sutterwala, F.S., Gorelik, L., Flavell, R.A. (2005). Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nature Immunology, 6, 600-607.10.1038/ni1197
  22. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β (1998). Annu. Rev. Immunol., 16, 137-161.10.1146/annurev.immunol.16.1.137
  23. Lu, L.-Y., Cheng, H-H, Sung, P.-K., Yeh, J.-J., Shiue, Y.-L., Chen, A. (2004). Single-nucleotide polymorphisms of transforming growth factor-g1 gene in Taiwanese patients with systemic lupus erythematosus. J. Microbiol. Immunol. Infect., 370(3), 135-142.
  24. Mahon, B.D., Gordon, S.A., Cruz, J., Cosman, F. Cantorna, M.T. (2003). Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol., 134, 128-132.10.1016/S0165-5728(02)00396-X
  25. Massague, J. (2000). How cell read TGF-β signals. Mol. Cell Biol., 1, 164-177.10.1038/3504305111252892
  26. Massague, J. (1990). The transforming growth factor-β family. Ann. Rev. Cell. Biol., 6, 597-641.10.1146/annurev.cb.06.110190.0031212177343
  27. Matsubara, T., Umezawa, Y., Tsuru, S., Motohashi, T., Yabuta, K., Furukawa, S. (1997). Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand. J. Rheumatol., 26(4), 314-317.10.3109/030097497091053229310113
  28. Mauviel, A. (2009). Transforming growth factor-beta signaling in skin: Stromal to epithelial cross-talk. J. Invest. Dermatol., 129(1), 7-9.10.1038/jid.2008.385
  29. Mieliauskaite, D., Venalis, P., Dumalakiene, I., Venalis, A., Distler, J. (2009). Relationship between serum levels of TGF-β1 and clinical parameters in patients with rheumatoid arthritis and Sjogren's syndrome secondary to rheumatoid arthritis. Autoimmunity, 42(4), 356-358.10.1080/08916930902831977
  30. Ohsugi, I., Imamura, O., Satoh, M., Sugawara, M., Goto, M., Sugimoto, M., Furuichi, Y. (2000). Overexpression of mRNAs of TGFβ-1 and related genes in fibroblasts of Werner syndrome patients. Mech. Ageing Devel., 115(3), 189-198.10.1016/S0047-6374(00)00122-6
  31. Oyama, N., Iwatsuki, K., Satoh, M., Akiba, H., Kaneko, F. (2000). Dermal fibroblasts are one of the therapeutic targets for topical applicationof 1α, 25 - dihydroxyvitamin D3, the possible involvement of transforming growth factor-β induction. Brit. J. Dermatol., 143, 1140-1148.10.1046/j.1365-2133.2000.03880.x
  32. Pardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., Moustakas, A. (2000). Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem., 275(38), 29244-29256.10.1074/jbc.M909467199
  33. Ravitz, M.J. (1997). Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation. Adv. Cancer Res., 71, 165-207.10.1016/S0065-230X(08)60099-8
  34. Rubtsov, Y.P., Rudensky, A.Y. (2007). TGF beta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol., 7(6), 443-453.10.1038/nri2095
  35. Saltis, J. (1996). TGF-beta: Receptors and cell cycle arrest. Mol. Cell Endocrinol., 116(2), 227-232.10.1016/0303-7207(95)03721-7
  36. Sellheyer, K., Bickenbach, J.R., Rothnagel, J.A. (1993). Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA, 90, 5237-5241.10.1073/pnas.90.11.5237466917685120
  37. Shen, L., Smith, J.M., Shen, Z., Eriksson, M., Sentman, C., Wira, C.R. (2007). Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin. Exp. Immunol., 149(1), 155-161.10.1111/j.1365-2249.2007.03376.x194202417403059
  38. Su, H., Ye, D.Q., Wang, B.L, Fang, X.H., Chen, J., Wang, Q., Li, W.X., Zhang, N. (2008). Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Brit. J. Dermatol., 158(6), 1197-1209.10.1111/j.1365-2133.2008.08555.x18410422
  39. Taihao, Q., Tianyuan, H., Sewon, K., Voorhees, J.J., Fisher, G. (2002). Ultraviolet irradiation alters transforming growth factor β/Smad pathway in human skin in vivo. J. Investig. Dermatol., 119, 499-506.10.1046/j.1523-1747.2002.01834.x12190876
  40. Ten Dijke, P., Goumans, M.J., Itoh, F., Itoh, S. (2002). Regulation of cell proliferation by Smad proteins. J. Cell Physiol., 191, 1-16.10.1002/jcp.1006611920677
  41. Ulloa, L, Doody, J., Massague, J. (1999). Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature, 397, 710-713.10.1038/1782610067896
  42. Van Ruissen, F., van Erp, P.E., de Jongh, G.J., Boezeman, J.B., van de Kerkhof, P.C., Schalkwijk, J. (1994). Cell kinetic characterization of growth arrest in cultured human keratinocytes J. Cell Sci., 107(8), 2219-2228.10.1242/jcs.107.8.22197983181
  43. Wang, X.-J., Greenhalgh, D.A., Bickenbach, J.R., Jiang, A., Bundman, D.S., Krieg, T., Derynck, R., Roop, D.R. (1997). Expression of a dominant-negative type II transforming receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc. Natl. Acad. Sci. USA, 94, 2386-2391.10.1073/pnas.94.6.2386200979122204
  44. Weichenthal, M, Schwarz, T. (2005). Phototherapy, how does UV work? Photodermatol Photoimmunol Photomed., 21, 260-266
  45. Widom, R.L. (2000). Regulation of matrix biosynthesis and degradation in systemic sclerosis. Curr. Opin. Rheumatol., 12(6), 534-539.10.1097/00002281-200011000-0001011092204
DOI: https://doi.org/10.2478/v10046-011-0022-4 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 80 - 86
Published on: Feb 15, 2012
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2012 Iveta Ivdra, Ilona Hartmane, Ingmars Mikažāns, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 65 (2011): Issue 3-4 (August 2011)